149 related articles for article (PubMed ID: 29768709)
1. Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.
van der Kolk T; Assil S; Rijneveld R; Klaassen ES; Feiss G; Florencia E; Prens EP; Burggraaf J; Moerland M; Rissmann R; van Doorn MBA
Clin Transl Sci; 2018 Nov; 11(6):607-615. PubMed ID: 29768709
[TBL] [Abstract][Full Text] [Related]
2. Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge model.
Assil S; Buters TP; Hameeteman PW; Hallard C; Treijtel N; Niemeyer-Van der Kolk T; de Kam ML; Florencia EFIII; Prens EP; van Doorn MBA; Rissmann R; Klarenbeek NB; Jansen MAA; Moerland M
Front Immunol; 2023; 14():1197650. PubMed ID: 37545524
[TBL] [Abstract][Full Text] [Related]
3. Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy Volunteers.
Niemeyer-van der Kolk T; Assil S; Buters TP; Rijsbergen M; Klaassen ES; Feiss G; Florencia E; Prens EP; Burggraaf J; van Doorn MBA; Rissmann R; Moerland M
Clin Transl Sci; 2020 May; 13(3):573-579. PubMed ID: 32043302
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate T
Garzorz-Stark N; Lauffer F; Krause L; Thomas J; Atenhan A; Franz R; Roenneberg S; Boehner A; Jargosch M; Batra R; Mueller NS; Haak S; Groß C; Groß O; Traidl-Hoffmann C; Theis FJ; Schmidt-Weber CB; Biedermann T; Eyerich S; Eyerich K
J Allergy Clin Immunol; 2018 Apr; 141(4):1320-1333.e11. PubMed ID: 28935206
[TBL] [Abstract][Full Text] [Related]
7. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
[TBL] [Abstract][Full Text] [Related]
9. Novel imiquimod nanovesicles for topical vaccination.
Caimi AT; Altube MJ; de Farias MA; Portugal RV; Perez AP; Romero EL; Morilla MJ
Colloids Surf B Biointerfaces; 2019 Feb; 174():536-543. PubMed ID: 30500742
[TBL] [Abstract][Full Text] [Related]
10. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G
PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells suppress skin inflammation in the imiquimod-induced psoriasis-like mouse model.
Choi CW; Kim BR; Yang S; Kim Y; Kang JS; Youn SW
J Dermatol Sci; 2020 Jun; 98(3):199-202. PubMed ID: 32451152
[No Abstract] [Full Text] [Related]
12. Microemulsions based on TPGS and isostearic acid for imiquimod formulation and skin delivery.
Pescina S; Garrastazu G; Del Favero E; Rondelli V; Cantù L; Padula C; Santi P; Nicoli S
Eur J Pharm Sci; 2018 Dec; 125():223-231. PubMed ID: 30316975
[TBL] [Abstract][Full Text] [Related]
13. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S
J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
15. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
[TBL] [Abstract][Full Text] [Related]
16. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Sathe P; Saka R; Kommineni N; Raza K; Khan W
Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
[TBL] [Abstract][Full Text] [Related]
17. Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice.
Bai S; Zhang Z; Hou S; Liu X
Mol Med Rep; 2016 Jul; 14(1):671-80. PubMed ID: 27221314
[TBL] [Abstract][Full Text] [Related]
18. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells.
Kiyohara H; Sujino T; Teratani T; Miyamoto K; Arai MM; Nomura E; Harada Y; Aoki R; Koda Y; Mikami Y; Mizuno S; Naganuma M; Hisamatsu T; Kanai T
Cell Mol Gastroenterol Hepatol; 2019; 7(1):135-156. PubMed ID: 30510995
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
